Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor VIII (FVIII) Gene”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Large-scale testing (Phase 3)WithdrawnNCT06297486
What this trial is testing

Study of a Gene Therapy Treatment for Hemophilia A

Who this might be right for
Hemophilia A
Spark Therapeutics, Inc.
Not applicableUnknownNCT05523128
What this trial is testing

The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.

Who this might be right for
Hemophilia A
Institute of Hematology & Blood Diseases Hospital, China 6
Testing effectiveness (Phase 2)Study completedNCT04684940
What this trial is testing

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia A With Anti Factor VIII
BioMarin Pharmaceutical 10
Large-scale testing (Phase 3)Study completedNCT03370913
What this trial is testing

Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)

Who this might be right for
Hemophilia A
BioMarin Pharmaceutical 144
Testing effectiveness (Phase 2)Study completedNCT03061201
What this trial is testing

Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

Who this might be right for
Hemophilia A
Pfizer 13
Testing effectiveness (Phase 2)Study completedNCT03489291
What this trial is testing

Dose Confirmation Trial of AAV5-hFIXco-Padua

Who this might be right for
Hemophilia B
CSL Behring 3
Large-scale testing (Phase 3)Study completedNCT03392974
What this trial is testing

Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg

Who this might be right for
Hemophilia A
BioMarin Pharmaceutical 1
Testing effectiveness (Phase 2)Study completedNCT03734588
What this trial is testing

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

Who this might be right for
Adeno-Associated Virus (AAV)Blood Coagulation DisorderBlood Coagulation Disorders, Inherited+14 more
Spark Therapeutics, Inc. 4
Testing effectiveness (Phase 2)Ended earlyNCT04541628
What this trial is testing

Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A

Who this might be right for
Hemophilia A
Eli Lilly and Company 3
Large-scale testing (Phase 3)Study completedNCT03587116
What this trial is testing

Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Who this might be right for
Hemophilia BHemophilia A
Pfizer 212
Testing effectiveness (Phase 2)Study completedNCT03307980
What this trial is testing

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 21
Not applicableLooking for participantsNCT04817462
What this trial is testing

Liver Biopsy In Haemophilia Gene Therapy

Who this might be right for
Hemophilia B, SevereHemophilia A, Severe
University College, London 10
Not applicableNot Yet RecruitingNCT04883710
What this trial is testing

The World Federation of Hemophilia Gene Therapy Registry

Who this might be right for
Hemophilia
World Federation of Hemophilia 5,000
Early research (Phase 1)Ended earlyNCT01620801
What this trial is testing

Hemophilia B Gene Therapy With AAV8 Vector

Who this might be right for
Hemophilia B
Spark Therapeutics, Inc. 4
Not applicableEnrolling By InvitationNCT05768386
What this trial is testing

A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

Who this might be right for
Hemophilia A
BioMarin Pharmaceutical 172
Not applicableStudy completedNCT04723680
What this trial is testing

An Exploration of the Impact of Gene Therapy on the Lives of People With Haemophilia and Their Families

Who this might be right for
Hemophilia
Haemnet 69
Not applicableNot Yet RecruitingNCT05932914
What this trial is testing

Liver Biopsy Following Gene Therapy For Hemophilia

Who this might be right for
Hemophilia AHemophilia B
St. Jude Children's Research Hospital 8
Very early researchUnknownNCT05152732
What this trial is testing

Safety and Tolerability of VGB-R04 in Patients With Haemophilia B

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 3
Not applicableActive Not RecruitingNCT03432520
What this trial is testing

Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A

Who this might be right for
Hemophilia A
Spark Therapeutics, Inc. 29
Early research (Phase 1)Not Yet RecruitingNCT04418414
What this trial is testing

Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A

Who this might be right for
Hemophilia A
Expression Therapeutics, LLC 7
Next Page